Pharmacyte Biotech, Inc. Form 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by Pharmacyte Biotech, Inc. (PMCB) on November 7, 2022, reporting an event that occurred on November 1, 2022. The company is incorporated in Nevada and its common stock trades on The Nasdaq Stock Market LLC.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes.
Material Changes
On November 1, 2022, Jack E. Stover resigned from the Board of Directors, effective immediately. The company stated that Mr. Stover's decision was not the result of any disagreement with the Company.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, management commentary on operations, or discussion of risks and contingencies beyond the departure of the director.
Investor Verification Checklist
- Confirm the current composition of the Board of Directors following Mr. Stover's resignation.
- Verify if a replacement director has been appointed or if a vacancy remains.
- Review recent 10-Q or 10-K filings for the most up-to-date financial position, as this 8-K contains no financial data.